Stock Analysis on Net

Amgen Inc. (NASDAQ:AMGN)

$24.99

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Amgen Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

Microsoft Excel
Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Accounts payable
Accrued liabilities
Current portion of long-term debt
Current liabilities
Long-term debt, excluding current portion
Long-term deferred tax liabilities
Long-term tax liabilities
Other noncurrent liabilities
Noncurrent liabilities
Total liabilities
Common stock and additional paid-in capital; $0.0001 par value
Accumulated deficit
Accumulated other comprehensive loss
Stockholders’ equity
Total liabilities and stockholders’ equity

Based on: 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).


Accounts Payable
Accounts payable demonstrated a fluctuating pattern across the periods. Starting at 1,338 million USD in March 2020, it saw decreases and increases, notably rising to a peak of 3,010 million USD in June 2025, indicating increased short-term obligations over time.
Accrued Liabilities
Accrued liabilities generally increased throughout the timeline. Beginning at 8,649 million USD in March 2020, it peaked at 17,641 million USD in June 2025. This trend reflects growing expenses incurred but not yet paid.
Current Portion of Long-Term Debt
This line item showed significant volatility, with very low values (around 91 million USD) in mid-2020 and end of 2020, then spiking at various points, such as 5,528 million USD in June 2024. This suggests refinancing activities or varying repayment schedules.
Current Liabilities
Current liabilities fluctuated between approximately 9,953 million USD and 23,099 million USD. A general increasing trend is observable, with the highest values recorded in mid-2025, pointing to greater short-term debt obligations.
Long-Term Debt, Excluding Current Portion
Long-term debt values showed initial stability around 30,000 to 34,000 million USD from 2020 to 2021, followed by a significant increase to over 60,000 million USD during 2023 and 2024. This doubling signals increased leverage or debt financing in recent periods.
Long-Term Deferred Tax Liabilities
Data was only available from March 2024 onwards and showed a gradual decline from 2,354 million USD to 1,386 million USD by June 2025, reflecting a possible reduction in future tax obligations.
Long-Term Tax Liabilities
Long-term tax liabilities decreased overall from 8,111 million USD in March 2020 to 2,511 million USD by June 2025, showing a steady downward trend that could indicate effective tax management or reduced tax exposures.
Other Noncurrent Liabilities
Other noncurrent liabilities remained relatively stable, fluctuating narrowly between about 2,100 and 2,700 million USD, with no clear trend over the periods.
Noncurrent Liabilities
Noncurrent liabilities showed growth from about 40,357 million USD in March 2020 to a peak of 72,530 million USD by December 2023. Thereafter, it slightly declined, signaling increased long-term financial commitments but some stabilization toward 2025.
Total Liabilities
Total liabilities rose from 52,184 million USD in March 2020 to a peak of 90,922 million USD in December 2023, before decreasing modestly to about 80,469 million USD by June 2025. This overall increase reflects expanded financial leverage.
Common Stock and Additional Paid-in Capital
This equity component steadily increased from 31,525 million USD in March 2020 to 33,680 million USD by June 2025, indicating consistent capital injections or retained earnings allocated to equity.
Accumulated Deficit
The accumulated deficit deepened initially from -21,378 million USD in March 2020, reaching a trough of -29,568 million USD in March 2022. Subsequently, it improved toward -25,708 million USD by June 2025, indicating some recovery in retained earnings or profitability.
Accumulated Other Comprehensive Loss
Accumulated other comprehensive loss mostly fluctuated with minor variations, ranging between -903 million USD and -66 million USD, reflecting periodic changes in unrealized gains or losses on investments or other comprehensive income items.
Stockholders’ Equity
Stockholders’ equity showed considerable volatility, initially decreasing from 9,485 million USD in March 2020 to 916 million USD in March 2022, before rebounding to 7,428 million USD by December 2024. However, slight declines occurred after late 2024. This pattern suggests periods of both financial strain and recovery.
Total Liabilities and Stockholders’ Equity
The total capitalization rose from 61,669 million USD in March 2020 to a high near 97,154 million USD in December 2023, then gradually declined to about 87,897 million USD by June 2025. This reflects the overall scale of the balance sheet expanding, followed by some contraction.